Nova Mentis Life Science Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was CAD 0.302793 million compared to CAD 0.366789 million a year ago.
For the six months, net loss was CAD 0.830798 million compared to CAD 0.993723 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.